ALPHA
Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization tre… Read more
ALPHA (0303) - Net Assets
Latest net assets as of November 2025: RM202.29 Million MYR
Based on the latest financial reports, ALPHA (0303) has net assets worth RM202.29 Million MYR as of November 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM260.64 Million) and total liabilities (RM58.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM202.29 Million |
| % of Total Assets | 77.61% |
| Annual Growth Rate | 48.41% |
| 5-Year Change | 320.31% |
| 10-Year Change | N/A |
| Growth Volatility | 93.69 |
ALPHA - Net Assets Trend (2020–2025)
This chart illustrates how ALPHA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ALPHA (2020–2025)
The table below shows the annual net assets of ALPHA from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-05-31 | RM204.15 Million | +7.57% |
| 2024-05-31 | RM189.78 Million | +247.87% |
| 2023-05-31 | RM54.55 Million | -7.48% |
| 2022-05-31 | RM58.97 Million | +21.40% |
| 2021-05-31 | RM48.57 Million | +71.27% |
| 2020-05-31 | RM28.36 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ALPHA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 372.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (May 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RM55.97 Million | 28.26% |
| Other Components | RM142.07 Million | 71.74% |
| Total Equity | RM198.04 Million | 100.00% |
ALPHA Competitors by Market Cap
The table below lists competitors of ALPHA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
U-Best Polymer Industry Co Ltd
TWO:4714
|
$70.69 Million |
|
MEDIANA Co.Ltd
KQ:041920
|
$70.69 Million |
|
SHEPHERD NEAME P. CONS.
F:43Y
|
$70.70 Million |
|
Austriacard Holdings AG
F:ACQ0
|
$70.70 Million |
|
Asia Electronic Material Co Ltd
TWO:4939
|
$70.67 Million |
|
Grupo TMM SAB
PINK:GTMAY
|
$70.66 Million |
|
Fonet Bilgi Teknolojileri AS
IS:FONET
|
$70.63 Million |
|
7730
TW:7730
|
$70.62 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ALPHA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 187,433,834 to 198,040,000, a change of 10,606,166 (5.7%).
- Net income of 57,454,000 contributed positively to equity growth.
- Dividend payments of 46,170,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM57.45 Million | +29.01% |
| Dividends Paid | RM46.17 Million | -23.31% |
| Other Changes | RM-677.83K | -0.34% |
| Total Change | RM- | 5.66% |
Book Value vs Market Value Analysis
This analysis compares ALPHA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.87x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 80.53x to 6.87x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-05-31 | RM0.00 | RM0.28 | x |
| 2021-05-31 | RM0.01 | RM0.28 | x |
| 2022-05-31 | RM0.01 | RM0.28 | x |
| 2023-05-31 | RM0.01 | RM0.28 | x |
| 2024-05-31 | RM0.04 | RM0.28 | x |
| 2025-05-31 | RM0.04 | RM0.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ALPHA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 29.01%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 32.49%
- • Asset Turnover: 0.71x
- • Equity Multiplier: 1.27x
- Recent ROE (29.01%) is below the historical average (33.54%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 14.61% | 3.58% | 0.92x | 4.44x | RM778.20K |
| 2021 | -9.13% | -4.96% | 0.67x | 2.74x | RM-6.45 Million |
| 2022 | 35.35% | 15.70% | 0.85x | 2.65x | RM10.26 Million |
| 2023 | 103.19% | 38.73% | 1.43x | 1.86x | RM48.08 Million |
| 2024 | 28.24% | 31.59% | 0.73x | 1.22x | RM34.19 Million |
| 2025 | 29.01% | 32.49% | 0.71x | 1.27x | RM37.65 Million |
Industry Comparison
This section compares ALPHA's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $3,604,756,654
- Average return on equity (ROE) among peers: 22.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ALPHA (0303) | RM202.29 Million | 14.61% | 0.29x | $70.68 Million |
| TMC Life Sciences Bhd (0101) | $48.97 Million | 18.72% | 0.24x | $32.96 Million |
| Optimax Holdings Sdn Bhd (0222) | $20.79 Million | 21.38% | 1.70x | $17.14 Million |
| Cengild Medical Berhad (0243) | $9.79 Million | 40.37% | 3.81x | $11.79 Million |
| DC HEALTHCARE HOLDINGS BERHAD (0283) | $4.75 Million | 39.98% | 2.55x | $5.67 Million |
| Metro Healthcare Berhad (0329) | $34.34 Million | 27.49% | 0.46x | $4.10 Million |
| PMCK Berhad (0363) | $81.09 Million | 13.23% | 0.33x | $421.93 |
| IHH Healthcare Bhd (5225) | $25.90 Billion | 3.74% | 0.50x | $6.11 Billion |
| KPJ Healthcare Bhd (5878) | $2.74 Billion | 12.92% | 1.70x | $1.99 Billion |